How much is Tartu Loomakliinik worth in 2026?

Tartu Loomakliinik has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Tartu Loomakliinik raised?

Tartu Loomakliinik has raised N/A in total funding across 1 funding rounds.

Tartu Loomakliinik

Other Healthcare Services

Tartu Loomakliinik valuation and funding history | Last updated: December 20, 2024 | 1 funding rounds

Current Valuation

N/A

As of December 20, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding

Dec 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 20, 2024	Buyout/LBO (Add-on)†	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Tartu Loomakliinik is currently valued at N/A as of December 20, 2024.

Track Tartu Loomakliinik Valuation Updates

Get notified when Tartu Loomakliinik raises new funding or valuation changes

Explore More Data

Detailed analysis for Tartu Loomakliinik

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Tartu Loomakliinik's valuation history, funding rounds, and growth metrics.

No credit card required

What is Tartu Loomakliinik Worth in 2026?

Tartu Loomakliinik is a leading private company in the Other Healthcare Services sector. Track Tartu Loomakliinik's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Tartu Loomakliinik Valuation is Determined

Private company valuations like Tartu Loomakliinik's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.